Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sandesh Warudkar."'
Publikováno v:
IP International Journal of Orthopaedic Rheumatology. 7:93-100
Teriparatide (TPTD) (recombinant Parathyroid Hormone 1-34) is one of the pioneer osteo-anabolic agents approved for management of osteoporosis. Being an anabolic agent, it increases bone mineral density by inducing formation of new bone by the action
Autor:
Sandesh Warudkar
Publikováno v:
International Journal of Ophthalmology & Eye Science. :445-449
Publikováno v:
Rheumatology. 61
Background/Aims Tumor necrosis factor (TNF) blocking therapies like etanercept (ETN) have revolutionized the management of ankylosing spondylitis (AS). Clinical trials suggest that Etanercept exhibits beneficial effects in terms of improving disease
Publikováno v:
International Journal of Scientific Reports. 8:323
Background: The objectives of the study was to evaluate the demographic profile of benign prostatic hyperplasia (BPH) patients and prevalence of overactive bladder (OAB) among these patients.Methods: A real-world, retrospective, observational study (
Autor:
Sandesh Warudkar.
Publikováno v:
International Journal of Advanced Research. 6:406-410
Autor:
Sandesh Warudkar, Vinod Shinde
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 9:42
Background: Presently available antiepileptic drugs are effective in controlling seizures in more than half of patients of all epilepsy but use is often limited by adverse effects. H1 receptor antagonists, have a controversial status in patients of e
Autor:
Sandesh Warudkar.
Purpose: The purpose of this study was to evaluate the efficacy and safety profile of intravitreal injection of bevacizumab biosimilar (Zybev) for various retinal neovascular conditions. Methods: Retrospective analysis was carried out on 108 injectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8300971748e45980c6608e0d657e3bc9
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 7:1100
Background: Current antiepileptic drugs (AEDs) are effective in controlling seizures in about 70% patients but use is often limited by adverse effects. Promethazine, H1 receptor antagonist, has a controversial status in patients of epilepsy. Both pro